Cann Group Limited (ASX:CAN)

Market Cap	8.09M
Revenue (ttm)	15.51M
Net Income (ttm)	-47.60M
Shares Out	622.21M
EPS (ttm)	-0.10
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,041,085
Average Volume	1,437,416
Open	0.0130
Previous Close	0.0130
Day's Range	0.0130 - 0.0130
52-Week Range	0.0130 - 0.1277
Beta	1.07
RSI	35.02
Earnings Date	May 29, 2025

About Cann Group

Cann Group Limited, together with its subsidiaries, engages in the breeding, cultivating, manufacturing, and selling medicinal cannabis in Australia and Europe. It also licenses to undertake research and to cultivate cannabis for human medicinal and research purposes. The company was founded in 2014 and is based in Port Melbourne, Australia.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2014
• Country: Australia
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: CAN

Financial Performance

In 2024, Cann Group's revenue was 18.36 million, a decrease of -11.03% compared to the previous year's 20.63 million. Losses were -51.24 million, 51.6% more than in 2023.